148 results on '"Almond, C."'
Search Results
2. Improved Metrics After Implementation of a Clinical Stroke Pathway for Children on Ventricular Assist Devices
3. A Pediatric Heart Failure Registry: The Time for Action is Now
4. Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation
5. Dapagliflozin for Graft Dysfunction After Pediatric Heart Transplant
6. Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency
7. Associations between antibiotic prescriptions and recurrent urinary tract infections in female college students
8. (324) Stanford Pediatric Psychosocial Optimization Tool for Transplant
9. (1038) Racial Disparities in the Use of Ventricular Assist Devices (VADs) in US Children Listed for Heart Transplantation
10. (322) A Pediatric Heart Failure Registry is Needed: A Time for ACTION
11. Impact of the 2018 Adult Heart Allocation Change on Pediatric Donor Offers and Waitlist Outcomes
12. Immunosuppressant Drug Level Monitoring in Pediatric Heart Transplant Recipients: A Report from the TEAMMATE Trial
13. Major Adverse Dystrophinopathy Event Score as Marker of Cumulative Morbidity and Risk for Mortality in Boys with Duchenne Muscular Dystrophy
14. A Novel Approach to Pediatric Heart Failure Quality Improvement within the ACTION Network
15. (1370) - Exploring Factors Associated with Prolonged Intubation After Ventricular Assist Device Implantation in Children
16. (1353) - Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency
17. (1363) - Improved Metrics After Implementation of a Clinical Stroke Pathway for Children on Ventricular Assist Devices
18. (1340) - Dapagliflozin for Graft Dysfunction After Pediatric Heart Transplant
19. (1331) - A Pediatric Heart Failure Registry: The Time for Action is Now
20. (221) - Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation
21. Antithrombotic therapy for ventricular assist devices in children: do we really know what to do?
22. Impact of Institutional Routine Endomyocardial Surveillance Biopsy Practices on Rejection and Graft Survival in Pediatric Heart Transplantation
23. Association between Pre-Albumin and Malnutrition in Children with Advanced Heart Failure
24. (397) Use of the SherpaPak Cardiac Transport System for Infant and Pediatric Donor Hearts: An Initial Experience
25. (323) Suboptimal Titration of Heart Failure Medications in Pediatric Patients: Baseline Data from the ACTION Network
26. (1034) Racial and Geographic Disparities in Utilization of Listing by Exception Among US Children Listed for Heart Transplantation
27. (1036) Through the "Chimney": Berlin Heart Excor Pediatric Ventricular Assist Device Inflow Stenting via a Novel Direct Access to Inflow Tubing
28. PCN68 An Incremental Effectiveness Analysis of Lorlatinib for the Treatment of ALK-Positive Advanced Non-Small Cell Lung Cancer that has Progressed after Another ALK Tyrosine Kinase Inhibitor in Portugal
29. PCN107 Cost-Effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for NON-SMALL CELL LUNG Cancer in Greece
30. Association between Pre-Albumin and Malnutrition in Children with Advanced Heart Failure
31. Impact of High- vs. Low-Frequency Surveillance Endomyocardial Biopsy Strategy in Pediatric Heart Transplantation
32. The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial
33. Impact of Insurance Status on Pediatric Heart Transplant Recipients
34. Conversion from Compounded Liquid Prograf to Prograf Granules - Lessons Learned from Our Early Experience
35. PNS260 INCLUSION OF NEW STRATEGIES IN THE UK'S CANCER DRUG FUND: WHAT WAS DECIDED IN FRANCE?
36. Palliative Care Involvement in Pediatric VAD Patients - A Single Center Experience
37. Readmissionsfor Children Hospitalized with Heart Failure: Are Some ReadmissionsPreventable?
38. The First Analysis of the International Pediatric Heart Failure Registry (iPHFR) - Heart Failure Hospitalizations
39. The Cost-Effectiveness of Ustekinumab in Moderate to Severely Active Crohn’s Disease in Sweden
40. Surgical Strategy to Support Right Ventricle with HVAD RVAD: Right Atrial vs Right Ventricular Diaphragmatic Surface Cannulation
41. Impact of Left Ventricular Assist Device on End-Organ Function in US Children Awaiting Heart Transplant
42. Safety Problems Associated with Extemporaneously-Prepared Liquid Tacrolimus in US Children After Heart Transplantation
43. Compassionate Deactivation of Ventricular Assist Devices in Children: A Survey of Pediatric VAD Clinicians’ Perspectives and Practices
44. Double-blinded randomised placebo-controlled clinical trial of individualised homeopathic treatment of hyperthyroid cats
45. Outcomes of US Patients with Marfans Syndrome Listed for Heart Transplantation
46. US Center Variability Surrounding Wait List Inactivation Practices After VAD Implantation in Children
47. Venous Congestion Is Associated with Renal Impairment in Children with Cardiovascular Disease
48. Functional Status of Children Supported on LVADs at Transplant: How Does It Compare to Children on Inotropic Support?
49. (999) - Readmissionsfor Children Hospitalized with Heart Failure: Are Some ReadmissionsPreventable?
50. (379) - The First Analysis of the International Pediatric Heart Failure Registry (iPHFR) - Heart Failure Hospitalizations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.